Kathryn E. Wengel - 09 Feb 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role: EVP, Chief TO and Risk Officer
Signature: /s/ Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol: JNJ
Transactions as of: 09 Feb 2024
Net transactions value: -$4,284,721
Form type: 4
Filing time: 13 Feb 2024, 17:18:34 UTC
Previous filing: 12 Feb 2024
Next filing: 14 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JNJ	Common Stock	Options Exercise	$3,223,101	+35,638	+53%	$90.44	102,534	09 Feb 2024	Direct	F1
transaction	JNJ	Common Stock	Tax liability	$4,284,721	-27,333	-27%	$156.76	75,201	09 Feb 2024	Direct	F2
holding	JNJ	Common Stock						64	09 Feb 2024	By 401k	F3
holding	JNJ	Common Stock						281	09 Feb 2024	By ESOP	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JNJ	Employee Stock Options (Right to Buy)	Options Exercise	$3,223,101	-35,638	-100%	$90.44	0	09 Feb 2024	Common Stock	35,638	$90.44	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the auto-exercise of options immediately prior to their expiration.
F2	Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on the Form 4.
F3	Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
F4	Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).